BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25594065)

  • 1. Menin-mediated regulation of miRNA biogenesis uncovers the IRS2 pathway as a target for regulating pancreatic beta cells.
    Gurung B; Katona BW; Hua X
    Oncoscience; 2014; 1(9):562-6. PubMed ID: 25594065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menin is required for optimal processing of the microRNA let-7a.
    Gurung B; Muhammad AB; Hua X
    J Biol Chem; 2014 Apr; 289(14):9902-8. PubMed ID: 24563463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation by the menin pathway.
    Feng Z; Ma J; Hua X
    Endocr Relat Cancer; 2017 Oct; 24(10):T147-T159. PubMed ID: 28811300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An autoregulatory network between menin and pri-miR-24-1 is required for the processing of its specific modulator miR-24-1 in BON1 cells.
    Luzi E; Marini F; Ciuffi S; Galli G; Brandi ML
    Mol Biosyst; 2016 May; 12(6):1922-8. PubMed ID: 27098433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menin: a scaffold protein that controls gene expression and cell signaling.
    Matkar S; Thiel A; Hua X
    Trends Biochem Sci; 2013 Aug; 38(8):394-402. PubMed ID: 23850066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menin expression is regulated by transforming growth factor beta signaling in leukemia cells.
    Zhang H; Liu ZG; Hua XX
    Chin Med J (Engl); 2011 May; 124(10):1556-62. PubMed ID: 21740816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menin localization in cell membrane compartment.
    He X; Wang L; Yan J; Yuan C; Witze ES; Hua X
    Cancer Biol Ther; 2016; 17(1):114-22. PubMed ID: 26560942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-15a/miR-16-1 expression inversely correlates with cyclin D1 levels in Men1 pituitary NETs.
    Lines KE; Newey PJ; Yates CJ; Stevenson M; Dyar R; Walls GV; Bowl MR; Thakker RV
    J Endocrinol; 2018 Sep; 240(1):41-50. PubMed ID: 30389902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells.
    Schnepp RW; Chen YX; Wang H; Cash T; Silva A; Diehl JA; Brown E; Hua X
    Cancer Res; 2006 Jun; 66(11):5707-15. PubMed ID: 16740708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-24 regulates menin in the endocrine pancreas.
    Vijayaraghavan J; Maggi EC; Crabtree JS
    Am J Physiol Endocrinol Metab; 2014 Jul; 307(1):E84-92. PubMed ID: 24824656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menin represses tumorigenesis via repressing cell proliferation.
    Wu T; Hua X
    Am J Cancer Res; 2011; 1(6):726-39. PubMed ID: 22016823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression.
    Chen YX; Yan J; Keeshan K; Tubbs AT; Wang H; Silva A; Brown EJ; Hess JL; Pear WS; Hua X
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1018-23. PubMed ID: 16415155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor menin regulates expression of insulin-like growth factor binding protein 2.
    La P; Schnepp RW; D Petersen C; C Silva A; Hua X
    Endocrinology; 2004 Jul; 145(7):3443-50. PubMed ID: 15044367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
    Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
    Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global expression profiling of murine MEN1-associated tumors reveals a regulatory role for menin in transcription, cell cycle and chromatin remodelling.
    Mould AW; Duncan R; Serewko-Auret M; Loffler KA; Biondi C; Gartside M; Kay GF; Hayward NK
    Int J Cancer; 2007 Aug; 121(4):776-83. PubMed ID: 17455252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer.
    Dreijerink KMA; Groner AC; Vos ESM; Font-Tello A; Gu L; Chi D; Reyes J; Cook J; Lim E; Lin CY; de Laat W; Rao PK; Long HW; Brown M
    Cell Rep; 2017 Mar; 18(10):2359-2372. PubMed ID: 28273452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
    Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.
    Dreijerink KMA; Timmers HTM; Brown M
    Endocr Relat Cancer; 2017 Oct; 24(10):T135-T145. PubMed ID: 28811299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple endocrine neoplasia type 1: a chromatin writer's block.
    Dreijerink KM; Lips CJ; Timmers HT
    J Intern Med; 2009 Jul; 266(1):53-9. PubMed ID: 19522825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors.
    Milne TA; Hughes CM; Lloyd R; Yang Z; Rozenblatt-Rosen O; Dou Y; Schnepp RW; Krankel C; Livolsi VA; Gibbs D; Hua X; Roeder RG; Meyerson M; Hess JL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):749-54. PubMed ID: 15640349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.